Results 161 to 170 of about 80,664 (276)

Correspondence of Basal Forebrain Resting‐State Functional Connectivity and Cerebral Glucose Metabolism Alterations With Neurotransmitter Maps in Alzheimer's Disease

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 5, May 2026.
Altered functional connectivity of basal forebrain subregions (Ch1‐3, Ch4) and widespread cerebral hypometabolism were identified in Alzheimer's disease using simultaneous PET/MRI. Spatial correspondence with normative neurotransmitter receptor and transporter maps suggested that serotonergic and dopaminergic systems may contribute to AD‐related ...
Yujie He   +11 more
wiley   +1 more source

Disruption of Dopamine Homeostasis by Psychostimulants. [PDF]

open access: yesMol Neurobiol
Torres J   +3 more
europepmc   +1 more source

Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma

open access: yesClinical and Translational Medicine, Volume 16, Issue 5, May 2026.
Retroperitoneal sarcoma cells can secrete prolactin into the bloodstream, inducing hyperprolactinaemia, which subsequently triggers metabolic reprogramming, such as glucose metabolism. SOX4 can function as a transcription factor that facilitates PRL transcription.
Fu'an Xie   +21 more
wiley   +1 more source

Organic neuromorphic electronics powering intelligent sensory and edge computing systems

open access: yesInfoMat, Volume 8, Issue 5, May 2026.
Organic electronic materials are promising candidates for neuromorphic sensing applications, including chemical, physical, visual, and multimodal sensing, owing to their mechanical softness, biocompatibility, and intrinsic ionic–electronic coupling.
Seungjun Woo   +5 more
wiley   +1 more source

Mechanistic Insights of Zonisamide in Parkinson's Disease: A Systematic Review

open access: yesNeurology and Clinical Neuroscience, Volume 14, Issue 3, Page 200-206, May 2026.
ABSTRACT Zonisamide is an antiepileptic agent used as adjunctive therapy for Parkinson's Disease in Japan and studied more selectively elsewhere. Preclinical and early translational studies suggest that zonisamide may modulate several pathways relevant to Parkinson's Disease pathobiology, including dopaminergic neurotransmission, oxidative stress ...
Justin Kim   +3 more
wiley   +1 more source

Dopamine D2-receptor blockade in humans disrupts the effect of effort on learning. [PDF]

open access: yesPLoS Biol
Jarvis H   +5 more
europepmc   +1 more source

Dopamine D2 Receptor Dimer Formation [PDF]

open access: yesJournal of Biological Chemistry, 2001
Duncan Armstrong, Philip G. Strange
openaire   +1 more source

Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 2123-2138, May 2026.
Abstract Background and Purpose Subsets of midbrain dopamine (DA) neurons express the vesicular glutamate transporter VGLUT2 and can release the excitatory neurotransmitter glutamate. VGLUT2+ DA neurons of the substantia nigra pars compacta (SNc) were shown to be more resistant to neurodegeneration in animal models of Parkinson's disease (PD ...
Sivakumar Srinivasan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy